Novacyt Stock

Novacyt Debt 2024

Novacyt Debt

-29.63 GBP

Ticker

ALNOV.PA

ISIN

FR0010397232

WKN

A12CFH

In 2024, Novacyt's total debt was -29.63 GBP, a -65.59% change from the -86.1 GBP total debt recorded in the previous year.

Novacyt Aktienanalyse

What does Novacyt do?

Novacyt SA is a leading biotechnology company specializing in the development and marketing of diagnostic products and technologies. The company was founded in 2006 and has experienced impressive growth since then. Its headquarters are located in Paris. Novacyt's business model revolves around the development and marketing of diagnostic products and technologies, particularly molecular diagnostic kits and reagents used for identification and quantification of microorganisms, viruses, and genetic differences. These products are commonly used in medical research, clinical diagnostics, and environmental analysis. Novacyt is divided into several divisions, each offering different products and services. Its diagnostic business specializes in the research, development, and marketing of molecular diagnostic kits, including the Primerdesign Kits specifically designed for COVID-19 identification. The company also provides laboratory and service offerings, such as DNA sequencing, qPCR analysis, sample preparation, and PCR disinfection. Additionally, Novacyt offers various diagnostic tests capable of detecting genetic differences and mutations. Its PathFlow division focuses on improving the process from diagnosis to therapy and follow-up, particularly for oncology patients. In response to the COVID-19 pandemic, Novacyt quickly launched a PCR test kit for COVID-19, which has been approved in numerous countries worldwide. Novacyt has successfully established itself as a key player in the fight against the pandemic. In summary, Novacyt SA is a leading biotechnology company specializing in the development and marketing of diagnostic products and technologies. Through its divisions, the company ensures the optimal utilization of molecular diagnostic tests. Novacyt has become an important player in the fight against the pandemic through its rapid response and development of molecular diagnostic kits for COVID-19, establishing itself as a reliable and innovative partner for medical research and clinical diagnostics. Novacyt ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Novacyt's Debt Structure

Novacyt's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Novacyt's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Novacyt’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Novacyt’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Novacyt stock

What is the debt of Novacyt this year?

Novacyt has a debt level of -29.63 GBP this year.

What was the debt of Novacyt compared to the previous year?

The debt of Novacyt has increased by -65.59% compared to the previous year dropped.

What are the consequences of high debt for investors in Novacyt?

High debt can pose a risk for investors of Novacyt, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Novacyt?

Low debt means that Novacyt has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Novacyt affect the company?

An increase in debt of Novacyt can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Novacyt affect the company?

A reduction in debt of Novacyt can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Novacyt?

Some factors that can influence the debt of Novacyt include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Novacyt so important for investors?

The debts of Novacyt are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Novacyt take to change the debt?

To change the debt, Novacyt can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Novacyt pay?

Over the past 12 months, Novacyt paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Novacyt is expected to pay a dividend of 0 GBP.

What is the dividend yield of Novacyt?

The current dividend yield of Novacyt is .

When does Novacyt pay dividends?

Novacyt pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Novacyt?

Novacyt paid dividends every year for the past 0 years.

What is the dividend of Novacyt?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Novacyt located?

Novacyt is assigned to the 'Health' sector.

Wann musste ich die Aktien von Novacyt kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Novacyt from 8/17/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 8/17/2024.

When did Novacyt pay the last dividend?

The last dividend was paid out on 8/17/2024.

What was the dividend of Novacyt in the year 2023?

In the year 2023, Novacyt distributed 0 GBP as dividends.

In which currency does Novacyt pay out the dividend?

The dividends of Novacyt are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Novacyt

Our stock analysis for Novacyt Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Novacyt Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.